Acadia Healthcare (NASDAQ:ACHC) Given Market Perform Rating at Leerink Partners

Acadia Healthcare (NASDAQ:ACHC)‘s stock had its “market perform” rating reissued by equities researchers at Leerink Partners in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $14.00 price objective on the stock, down from their previous price objective of $25.00. Leerink Partners’ price objective suggests a potential downside of 15.10% from the stock’s current price.

A number of other research analysts have also recently issued reports on the stock. Raymond James Financial set a $22.00 target price on shares of Acadia Healthcare in a report on Friday, November 7th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $20.00 price target on shares of Acadia Healthcare in a research report on Wednesday. Cantor Fitzgerald decreased their price objective on shares of Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Friday, November 7th. UBS Group restated a “buy” rating on shares of Acadia Healthcare in a report on Wednesday. Finally, Mizuho lowered their price target on shares of Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 13th. Eight investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Hold” and a consensus target price of $26.25.

Acadia Healthcare Stock Down 2.1%

ACHC opened at $16.49 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44. Acadia Healthcare has a 12 month low of $14.30 and a 12 month high of $47.08. The stock has a market capitalization of $1.52 billion, a P/E ratio of 14.09, a P/E/G ratio of 3.59 and a beta of 0.91. The business has a 50 day simple moving average of $21.24 and a 200-day simple moving average of $21.89.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. The firm had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.Acadia Healthcare’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, equities analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of ACHC. Wellington Management Group LLP raised its stake in Acadia Healthcare by 11.8% during the third quarter. Wellington Management Group LLP now owns 9,423,548 shares of the company’s stock worth $233,327,000 after purchasing an additional 993,205 shares during the period. Vanguard Group Inc. boosted its holdings in Acadia Healthcare by 7.8% in the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock valued at $233,166,000 after acquiring an additional 681,278 shares during the last quarter. Abrams Bison Investments LLC grew its position in Acadia Healthcare by 22.3% during the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after acquiring an additional 800,000 shares during the period. UBS Group AG increased its stake in Acadia Healthcare by 8.8% during the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after acquiring an additional 350,484 shares during the last quarter. Finally, State Street Corp raised its holdings in shares of Acadia Healthcare by 3.2% in the 2nd quarter. State Street Corp now owns 3,095,775 shares of the company’s stock worth $70,243,000 after purchasing an additional 95,670 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.